Nyante S, Dallal C, Gierach G, Park Y, Hollenbeck A, Brinton L
Am J Epidemiol. 2013; 178(3):359-71.
PMID: 23899816
PMC: 3727333.
DOI: 10.1093/aje/kws471.
Fayanju O, Jeffe D, Elmore L, Ksiazek D, Margenthaler J
Ann Surg Oncol. 2012; 20(3):723-32.
PMID: 23070783
PMC: 3707610.
DOI: 10.1245/s10434-012-2558-1.
Ozmen V, Ozcinar B, Karanlik H, Cabioglu N, Tukenmez M, Disci R
World J Surg Oncol. 2009; 7:37.
PMID: 19356229
PMC: 2678125.
DOI: 10.1186/1477-7819-7-37.
Dolle J, Daling J, White E, Brinton L, Doody D, Porter P
Cancer Epidemiol Biomarkers Prev. 2009; 18(4):1157-66.
PMID: 19336554
PMC: 2754710.
DOI: 10.1158/1055-9965.EPI-08-1005.
Wiseman R
J Epidemiol Community Health. 2000; 54(11):851-8.
PMID: 11027200
PMC: 1731579.
DOI: 10.1136/jech.54.11.851.
Oral contraceptive use at a young age and the risk of breast cancer: an Icelandic, population-based cohort study of the effect of birth year.
Tryggvadottir L, Tulinius H, Gudmundsdottir G
Br J Cancer. 1997; 75(1):139-43.
PMID: 9000612
PMC: 2222710.
DOI: 10.1038/bjc.1997.23.
Recent oral contraceptive use and risk of breast cancer (United States).
Newcomb P, Longnecker M, Storer B, Mittendorf R, Baron J, Clapp R
Cancer Causes Control. 1996; 7(5):525-32.
PMID: 8877050
DOI: 10.1007/BF00051885.
Progestogen-only oral contraceptives and risk of breast cancer in New Zealand.
Skegg D, Paul C, SPEARS G, Williams S
Cancer Causes Control. 1996; 7(5):513-9.
PMID: 8877048
DOI: 10.1007/BF00051883.
Ascertainment of familial ovarian cancer in the Aberdeen Genetic Clinic.
Gregory H, Schofield A, De Silva D, Semper J, Milner B, Allan L
J Med Genet. 1996; 33(3):187-92.
PMID: 8728689
PMC: 1051865.
DOI: 10.1136/jmg.33.3.187.
Oral contraceptives and cancer. A review of the evidence.
La Vecchia C, Tavani A, Franceschi S, Parazzini F
Drug Saf. 1996; 14(4):260-72.
PMID: 8713694
DOI: 10.2165/00002018-199614040-00006.
Oral contraceptive use and risk of breast cancer in older women (New Zealand).
Paul C, Skegg D, SPEARS G
Cancer Causes Control. 1995; 6(6):485-91.
PMID: 8580295
DOI: 10.1007/BF00054155.
Exogenous hormone use and the risk of postmenopausal breast cancer: results from The Netherlands Cohort Study.
Schuurman A, van den Brandt P, Goldbohm R
Cancer Causes Control. 1995; 6(5):416-24.
PMID: 8547539
DOI: 10.1007/BF00052181.
Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use.
dos Santos Silva I, Swerdlow A
Br J Cancer. 1995; 72(2):485-92.
PMID: 7640237
PMC: 2033995.
DOI: 10.1038/bjc.1995.360.
Cigarette smoking and breast cancer.
Bennicke K, Conrad C, Sabroe S, Sorensen H
BMJ. 1995; 310(6992):1431-3.
PMID: 7613275
PMC: 2549812.
DOI: 10.1136/bmj.310.6992.1431.
Studying environmental influences and breast cancer risk: suggestions for an integrated population-based approach.
Millikan R, Devoto E, Newman B, Savitz D
Breast Cancer Res Treat. 1995; 35(1):79-89.
PMID: 7612908
DOI: 10.1007/BF00694748.
Oral contraceptive use and breast cancer risk among African-American women.
Palmer J, Rosenberg L, Rao R, Strom B, Warshauer M, Harlap S
Cancer Causes Control. 1995; 6(4):321-31.
PMID: 7548719
DOI: 10.1007/BF00051407.
